Glumex Pharmaceuticals Manufacturing Pvt Ltd., a active private limited company, was established on 17 July 1989 in Vasai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MH1989PTC052620. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹7.29 M.
It upholds a compliant status. Employing 47 professional, Its leadership includes Ushma Apurva Shah (Director), Apurva Pradeep Shah (Director). Past directors included Ushma Apurva Shah, Pradeep Bhukandas Shah. It holds ₹8.53 Cr open charges and ₹12.75 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Saraswati Gala No-41,, Tungareshwar Indl, Sativali, Vasai, Maharashtra, 401208.
U24230MH1989PTC052620
052620
17 July 1989
₹2.00 Cr
₹7.29 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Glumex Pharmaceuticals Manufacturing Pvt Ltd. — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ushma Apurva Shah | Director | 26 Oct 2020 | Current |
| Apurva Pradeep Shah | Director | 12 Sep 2005 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Dec 2020 | Past |
| Pramod Abcsdd | Director | 21 Nov 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Glumex Pharmaceuticals Manufacturing Pvt Ltd., for the financial year ended 2023, experienced modest growth in revenue, with a 7% increase. The company also saw a substantial fall in profitability, with a 3852.79% decrease in profit. The company's net worth observed a substantial decline by a decrease of 25.44%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Glumex Pharmaceuticals Manufacturing's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹85,332,661.00
₹127,477,593.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Aug 2024 | Others | ₹5.70 Cr | Open |
| 29 Aug 2024 | Others | ₹2.00 Cr | Open |
| 29 Aug 2024 | Others | ₹2.10 M | Open |
| 29 Aug 2024 | Others | ₹4.50 M | Open |
| 21 Dec 2020 | Hdfc Bank Limited | ₹1.13 M | Open |
Explore comprehensive loan charge details -
Glumex Pharmaceuticals Manufacturing has a workforce of 47 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Glumex Pharmaceuticals Manufacturing, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glumex Pharmaceuticals Manufacturing's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others of Rs. 5.70 Cr registered on 29 Aug 2024 with Charge ID 100980733 was modified on 15 Oct 2024. was recorded as a recent event.
Progress on A charge with Others of Rs. 2.00 Cr registered on 29 Aug 2024 with Charge ID 100980731 was modified on 15 Oct 2024. was documented.
The activity A charge with Others of Rs. 0.21 Cr registered on 29 Aug 2024 with Charge ID 100980729 was modified on 15 Oct 2024. was completed.
The activity A charge with Others of Rs. 0.45 Cr registered on 29 Aug 2024 with Charge ID 100980727 was modified on 15 Oct 2024. was completed.
Progress on A charge registered on 17 Dec 2016 via Charge ID 100074165 with Yes Bank Limited was fully satisfied on 08 Oct 2024. was documented.
Progress on Glumex Pharmaceuticals Manufacturing Pvt Ltd. last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The CIN of Glumex Pharmaceuticals Manufacturing Pvt Ltd. is U24230MH1989PTC052620.
Glumex Pharmaceuticals Manufacturing Pvt Ltd. is headquartered at Saraswati Gala No-41,, Tungareshwar Indl, Sativali, Vasai, Maharashtra, 401208.
Glumex Pharmaceuticals Manufacturing Pvt Ltd. was incorporated on 17 July 1989.
The current directors of Glumex Pharmaceuticals Manufacturing Pvt Ltd. are
The primary industry of Glumex Pharmaceuticals Manufacturing Pvt Ltd. is Manufacturing.
Glumex Pharmaceuticals Manufacturing Pvt Ltd. is unlisted.
The authorized capital of Glumex Pharmaceuticals Manufacturing Pvt Ltd. is ₹2.00 Cr, and the paid-up capital is ₹7.29 M.
The compliance status of Glumex Pharmaceuticals Manufacturing Pvt Ltd. is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX